Description
Rubraca (rucaparib) is a PARP inhibitor indicated for certain ovarian, fallopian tube, or primary peritoneal cancers.
$1,772.60
PARP inhibitor for gynaecological cancers
Rubraca (rucaparib) is a PARP inhibitor indicated for certain ovarian, fallopian tube, or primary peritoneal cancers.
Reviews
There are no reviews yet.